{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T22:00:28Z","timestamp":1764540028776},"reference-count":41,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.leukres.2007.12.010","type":"journal-article","created":{"date-parts":[[2008,3,6]],"date-time":"2008-03-06T23:25:29Z","timestamp":1204845929000},"page":"1400-1406","source":"Crossref","is-referenced-by-count":5,"title":["PRAME expression in hairy cell leukemia"],"prefix":"10.1016","volume":"32","author":[{"given":"Evgeny","family":"Arons","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Suntum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inger","family":"Margulies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constance","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryalice","family":"Stetler-Stevenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Kreitman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2007.12.010_bib1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)80426-4","article-title":"Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor","volume":"6","author":"Ikeda","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.leukres.2007.12.010_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1084\/jem.193.1.73","article-title":"Efficient identification of novel HLA-A(*)0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis","volume":"193","author":"Kessler","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2007.12.010_bib3","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.ejca.2006.06.026","article-title":"Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors","volume":"42","author":"Partheen","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.leukres.2007.12.010_bib4","article-title":"Prevalence and prognostic and predictive relevance of PRAME in breast cancer","author":"Doolan","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.leukres.2007.12.010_bib5","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1038\/sj.onc.1207043","article-title":"Comparison of medulloblastoma and normal neural transcriptomes identifies a restricted set of activated genes","volume":"22","author":"Boon","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2007.12.010_bib6","first-page":"2","article-title":"Identification of cancer-testis genes expressed by melanoma and soft tissue sarcoma using bioinformatics","volume":"5","author":"Segal","year":"2005","journal-title":"Cancer Immun"},{"key":"10.1016\/j.leukres.2007.12.010_bib7","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/hed.20380","article-title":"Expression of cancer testis antigens in head and neck squamous cell carcinomas","volume":"28","author":"Figueiredo","year":"2006","journal-title":"Head Neck"},{"key":"10.1016\/j.leukres.2007.12.010_bib8","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1158\/1078-0432.CCR-03-0813","article-title":"The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome","volume":"10","author":"Oberthuer","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2007.12.010_bib9","first-page":"4090","article-title":"Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies?","volume":"58","author":"Neumann","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2007.12.010_bib10","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0002-9440(10)61166-2","article-title":"Gene expression in Wilms\u2019 tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition","volume":"160","author":"Li","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.leukres.2007.12.010_bib11","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1046\/j.1365-2141.1998.00982.x","article-title":"PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells","volume":"102","author":"van Baren","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2007.12.010_bib12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0145-2126(02)00217-5","article-title":"The expression of PRAME in chronic lymphoproliferative disorders","volume":"27","author":"Proto-Siqueira","year":"2003","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2007.12.010_bib13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ajh.20425","article-title":"PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects","volume":"79","author":"Paydas","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2007.12.010_bib14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ijc.11623","article-title":"mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies","volume":"108","author":"Greiner","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.leukres.2007.12.010_bib15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0165-4608(01)00570-2","article-title":"Clinical implications of PRAME gene expression in childhood acute myeloid leukemia","volume":"133","author":"Steinbach","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.leukres.2007.12.010_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0165-4608(02)00582-4","article-title":"PRAME gene expression in childhood acute lymphoblastic leukemia","volume":"138","author":"Steinbach","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.leukres.2007.12.010_bib17","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1515\/CCLM.2006.106","article-title":"Real-time RT-PCR quantification of PRAME gene expression for monitoring minimal residual disease in acute myeloblastic leukaemia","volume":"44","author":"Tajeddine","year":"2006","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.leukres.2007.12.010_bib18","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1046\/j.1365-2141.2001.02670.x","article-title":"Quantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukaemia","volume":"112","author":"Matsushita","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2007.12.010_bib19","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1073\/pnas.0510423103","article-title":"Gene expression changes associated with progression and response in chronic myeloid leukemia","volume":"103","author":"Radich","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2007.12.010_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2007.02.016","article-title":"Epigenetic regulation of PRAME gene in chronic myeloid leukemia","author":"Roman-Gomez","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2007.12.010_bib21","first-page":"596","article-title":"Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma","volume":"91","author":"Willenbrock","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2007.12.010_bib22","first-page":"77","article-title":"Expression of PRAME gene in multiple myeloma","volume":"76","author":"Abramenko","year":"2004","journal-title":"Ter Arkh"},{"key":"10.1016\/j.leukres.2007.12.010_bib23","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/1521-4141(200003)30:3<803::AID-IMMU803>3.0.CO;2-P","article-title":"The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cells","volume":"30","author":"Pellat-Deceunynck","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.leukres.2007.12.010_bib24","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.leukres.2006.02.031","article-title":"PRAME is a membrane and cytoplasmic protein aberrantly expressed in chronic lymphocytic leukemia and mantle cell lymphoma","volume":"30","author":"Proto-Siqueira","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2007.12.010_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.leukres.2006.06.022","article-title":"PRAME mRNA levels in cases with chronic leukemia: clinical importance and review of the literature","volume":"31","author":"Paydas","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2007.12.010_bib26","first-page":"95","article-title":"Expression of RHAMM\/CD168 and other tumor-associated antigens in patients with B-cell chronic lymphocytic leukemia","volume":"29","author":"Giannopoulos","year":"2006","journal-title":"Int J Oncol"},{"key":"10.1016\/j.leukres.2007.12.010_bib27","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2005.07.003","article-title":"The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling","volume":"122","author":"Epping","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2007.12.010_bib28","doi-asserted-by":"crossref","first-page":"7348","DOI":"10.1158\/0008-5472.CAN-04-4011","article-title":"Tumor-associated antigen preferentially expressed antigen of melanoma (PRAME) induces caspase-independent cell death in vitro and reduces tumorigenicity in vivo","volume":"65","author":"Tajeddine","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2007.12.010_bib29","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/gcc.20465","article-title":"Hypomethylation of PRAME is responsible for its aberrant overexpression in human malignancies","volume":"46","author":"Schenk","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.leukres.2007.12.010_bib30","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.leukres.2006.06.006","article-title":"Quantitative assessment of PRAME expression in diagnosis of childhood acute leukemia","volume":"31","author":"Spanaki","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2007.12.010_bib31","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2141.2006.06066.x","article-title":"Somatic hypermutation and VH gene usage in hairy cell leukemia","volume":"133","author":"Arons","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2007.12.010_bib32","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1038\/sj.leu.2403503","article-title":"V(H) gene analysis of hairy cell leukemia reveals a homogeneous mutation status and suggests its marginal zone B-cell origin","volume":"18","author":"Vanhentenrijk","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2007.12.010_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1309\/G6299513NGLCUB1K","article-title":"Minimal residual disease detection in hairy cell leukemia. Comparison of flow cytometric immunophenotyping with clonal analysis using consensus primer polymerase chain reaction for the heavy chain gene","volume":"119","author":"Sausville","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.leukres.2007.12.010_bib34","doi-asserted-by":"crossref","first-page":"8424","DOI":"10.4049\/jimmunol.175.12.8424","article-title":"Expression and activity of NOX5 in the circulating malignant B cells of hairy cell leukemia","volume":"175","author":"Kamiguti","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.leukres.2007.12.010_bib35","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00062752-200307000-00002","article-title":"Hairy cell leukemia: an update","volume":"10","author":"Goodman","year":"2003","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.leukres.2007.12.010_bib36","first-page":"402","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods Cell Biol"},{"key":"10.1016\/j.leukres.2007.12.010_bib37","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/sj.leu.2402880","article-title":"Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies","volume":"17","author":"Lossos","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2007.12.010_bib38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJM200107263450402","article-title":"Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia","volume":"345","author":"Kreitman","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2007.12.010_bib39","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1200\/JCO.2005.11.437","article-title":"Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignancies","volume":"23","author":"Kreitman","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2007.12.010_bib40","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1158\/1078-0432.CCR-05-2315","article-title":"Minimal residual disease in hairy cell leukemia patients assessed by clone-specific polymerase chain reaction","volume":"12","author":"Arons","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2007.12.010_bib41","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.leukres.2006.11.019","article-title":"Immunoglobulin light chain repertoire in hairy cell leukemia","volume":"31","author":"Arons","year":"2007","journal-title":"Leuk Res"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212607005024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212607005024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T07:25:48Z","timestamp":1546241148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212607005024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0145212607005024"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2007.12.010","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}